NCT02180659View on ClinicalTrials.gov

A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants

PHASE3CompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Opioid Dependence
Interventions
DRUG

sublingual buprenorphine tablets

DRUG

Buprenorphine implant

DRUG

placebo implants

DRUG

sublingual placebo tablets

Sponsors
All Listed Sponsors
lead

Titan Pharmaceuticals

INDUSTRY

NCT02180659 - A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants | Biotech Hunter | Biotech Hunter